- About Terumo
- Business Overview
- March 02, 2023Corporate
- February 23, 2023CorporateTerumo Blood and Cell Technologies Presents First Quantum Flex Data for Multiple Size Bioreactors Showing Rapid T-Cell Expansion to Numbers Equivalent to a Therapeutic Dose
Presentation at CAR-TCR Summit Europe demonstrates scalability and reduced media usage enable lower cost to produce a dose of autologous T-cell therapy
- Global Network
Terumo goes beyond boundaries—of R&D and production, of regions and functions, inside and outside the company—to further
evolve the technologies we have cultivated across decades and develop unprecedented new technologies.
At the root of this work lies the Terumo Corporate Mission of Contributing to Society through Healthcare.
We strive to continually bring products of value to patients and medical settings throughout the world.